hello world
Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.
Stocks in play: Microbix Biosystems Inc.
Reports results for its second quarter and first half of fiscal 2024 ended March 31. Q2 revenue was $5,632,901, a 34% increase from Q2 2023 revenues of $4,218,323. Increased sales and higher gross margin dollars led to an operating income and net income of $377,730 versus a Q2 2023 operating income and net income of $31,616. Microbix Biosystems Inc. shares T.MBX are trading up $0.02 at $0.34.
